Magnesium Supplements for Anxiety: What Trials Show

What the evidence shows

A review found mixed results across groups considered vulnerable to anxiety.
One open-label trial reported lower anxiety scores in adults with depression.
A stressed-adult study compared magnesium with magnesium plus vitamin B6, not with a dummy pill.
Reviews and guidelines describe important limits in the evidence.

What the studies examined

Research suggests possible effects in some groups, but does not settle whether magnesium reduces anxiety broadly. A 2017 systematic review included 18 studies of magnesium alone or with up to five other ingredients.

All studies enrolled groups considered vulnerable to anxiety. These groups included mildly anxious people, people with premenstrual syndrome, postpartum people, and people with hypertension.

Four of eight studies in anxious groups reported lower subjective anxiety. Four of seven premenstrual studies and one of two hypertension studies also reported benefit. Magnesium had no effect on postpartum anxiety.

No study used a validated measure of subjective stress. The reviewers called the evidence poor, despite signs of possible benefit in these groups.

A randomized trial in adults with depression

A 2017 randomized trial enrolled adults with diagnosed, mild-to-moderate depression in outpatient primary care. This was not an anxiety-only sample. Participants averaged 52 years old, and 38% were male. Of 126 participants, 112 provided analyzable data.

The open-label crossover study compared six weeks of magnesium chloride with six weeks without treatment. Open-label means the study did not hide treatment assignment. The magnesium period used 248 mg of elemental magnesium daily.

The net change on the GAD-7 anxiety score was −4.5 points (95% CI, −6.6 to −2.4; p < 0.001). Depression scores also improved by 6.0 net points on the PHQ-9 (95% CI, −7.9 to −4.2; p < 0.001).

Effects appeared within two weeks. Similar effects were reported across age, sex, depression severity, blood magnesium levels, and antidepressant use. Adherence averaged 83% by pill count. The supplement was well tolerated, and 61% said they would use magnesium in the future.

The lack of blinding and the no-treatment comparison leave room for expectations to affect self-rated scores.

A secondary analysis in stressed adults

A 2021 post-hoc analysis examined outcomes from an eight-week randomized study. Participants were healthy adults with low blood magnesium and severe or extremely severe stress.

The study compared magnesium alone with magnesium plus vitamin B6. Both groups’ anxiety and depression scores improved significantly by week eight, especially during the first four weeks. Quality of life improved over eight weeks. At week four, perceived daily physical activity capacity improved more in the group that also received vitamin B6.

This was a secondary analysis, not the study’s original main question. Because both groups received magnesium, the comparison cannot show magnesium’s effect against no magnesium.

Blood magnesium findings are not supplement trial results

A 2020 systematic review collected 32 papers on several mental health conditions, including four on anxiety disorders.

Two papers found no significant link between blood magnesium and panic disorder or generalized anxiety disorder. Two other papers linked higher magnesium levels with lower anxiety scores in depressed patients. They also reported beneficial magnesium levels in stressed patients.

These findings concern magnesium levels, not clear proof that supplements lower anxiety. The review said findings on magnesium levels and supplement effects were not consistent. It called for trials testing magnesium alone or with antidepressants.

How guidelines judged the evidence

A 2022 international guideline review used a high evidence bar: a meta-analysis or two or more randomized trials. It excluded single trials and lower-level reports from its recommendations.

Among nutraceuticals, the taskforce found no adequate evidence for anxiety-related disorders, except weak support for N-acetyl cysteine in OCD-related disorders. It did not support magnesium alone for unipolar depression.

The guideline also noted that missing evidence does not prove an intervention cannot work. Its conclusion reflects its evidence threshold, not proof that magnesium has no effect.

What the evidence can support

The findings vary by population and study design. Positive anxiety-score results come from selected groups or studies with limits. Some reports examined blood magnesium levels rather than supplements.

The open-label trial found lower anxiety scores, but enrolled people with depression and used no-treatment control. The stressed-adult analysis compared two magnesium-containing groups. Neither result settles magnesium’s effect in people with anxiety broadly.

The 2017 review called for well-designed randomized trials. Current evidence remains suggestive, not conclusive.

Sources

About this article

NootroWorld publishes research summaries, not medical advice. This article describes what studies have and have not established; it does not tell you what to take. Supplements can interact with medication, pregnancy and existing health conditions, and study populations often differ from your own situation. Discuss any personal decision with a qualified healthcare professional.